Showing results (641-650 of 693) with videos related to
Sort By:
Pageof 70
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.The Journal of Biological Chemistry|April 5, 2011
Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I)Friedrich Metzger, Waseem Sajid, Stefanie Saenger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemiaEyal C Attar, Daniel J De Angelo, Jeffrey G Supko, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 27, 2022
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)Melissa Amrein, Xinmin S Li, Joan Walter, et al.Journal of Critical Care|June 23, 2020
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international surveyAlexis Tabah, Mahesh Ramanan, Kevin B Laupland, et al.Cells|April 25, 2025
Hypothermia Shifts Neurodegeneration Phenotype in Neonatal Human Hypoxic-Ischemic Encephalopathy but Not in Related Piglet Models: Possible Relationship to Toxic Conformer and Intrinsically Disordered Prion-like Protein AccumulationLee J Martin, Jennifer K Lee, Mark V Niedzwiecki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502Eyal C Attar, Jeffrey L Johnson, Philip C Amrein, et al.The Lancet. Neurology|August 13, 2022
Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort studyIsabel R A Retel Helmrich, Endre Czeiter, Krisztina Amrein, et al.Ebiomedicine|May 29, 2020
Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI studyEndre Czeiter, Krisztina Amrein, Benjamin Y Gravesteijn, et al.Clinical Nutrition (Edinburgh, Scotland)|February 13, 2024
ESPEN practical short micronutrient guidelineMette M Berger, Alan Shenkin, Oguzhan Sıtkı Dizdar, et al.Pageof 70